PMID- 35032419 OWN - NLM STAT- MEDLINE DCOM- 20220214 LR - 20220214 IS - 1530-6860 (Electronic) IS - 0892-6638 (Linking) VI - 36 IP - 2 DP - 2022 Feb TI - Eukaryotic elongation factor 2 kinase regulates foam cell formation via translation of CD36. PG - e22154 LID - 10.1096/fj.202101034R [doi] AB - Eukaryotic elongation factor 2 kinase (eEF2K) is an atypical protein kinase that controls protein synthesis in cells under stress. Although well studied in cancer, less is known about its roles in chronic inflammatory diseases. Here, we examined its regulation of macrophage cholesterol handling in the context of atherosclerosis. eEF2K mRNA expression and protein activity were upregulated in murine bone marrow-derived macrophages (BMDMs) exposed to oxidized low-density lipoprotein cholesterol (oxLDL). When incubated with oxLDL, BMDMs from eEF2K knockout (Eef2k(-/-) ) mice formed fewer Oil Red O(+) foam cells than Eef2k(+/+) BMDMs (12.5% +/- 2.3% vs. 32.3% +/- 2.0%, p < .01). Treatment with a selective eEF2K inhibitor, JAN-384, also decreased foam cell formation for C57BL/6J BMDMs and human monocyte-derived macrophages. Disabling eEF2K selectively decreased protein expression of the CD36 cholesterol uptake receptor, mediated by a reduction in the proportion of translationally active Cd36 mRNA. Eef2k(-/-) mice bred onto the Ldlr(-/-) background developed aortic sinus atherosclerotic plaques that were 30% smaller than Eef2k(+/+) -Ldlr(-/-) mice after 16 weeks of high cholesterol diet (p < .05). Although accompanied by a reduction in plaque CD36(+) staining (p < .05) and lower CD36 expression in circulating monocytes (p < .01), this was not associated with reduced lipid content in plaques as measured by oil red O staining. Finally, EEF2K and CD36 mRNA levels were higher in blood mononuclear cells from patients with coronary artery disease and recent myocardial infarction compared to healthy controls without coronary artery disease. These results reveal a new role for eEF2K in translationally regulating CD36 expression and foam cell formation in macrophages. Further studies are required to explore therapeutic targeting of eEF2K in atherosclerosis. CI - (c) 2022 Federation of American Societies for Experimental Biology. FAU - Fernando, Sanuja AU - Fernando S AD - Vascular Research Centre, Heart and Vascular Program, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia. AD - Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia. FAU - Salagaras, Thalia AU - Salagaras T AD - Vascular Research Centre, Heart and Vascular Program, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia. FAU - Schwarz, Nisha AU - Schwarz N AD - Vascular Research Centre, Heart and Vascular Program, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia. FAU - Sandeman, Lauren AU - Sandeman L AD - Vascular Research Centre, Heart and Vascular Program, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia. AD - Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia. FAU - Tan, Joanne T M AU - Tan JTM AUID- ORCID: 0000-0003-1875-4882 AD - Vascular Research Centre, Heart and Vascular Program, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia. AD - Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia. FAU - Xie, Jianling AU - Xie J AD - Lifelong Health in Nutrition and Metabolism, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia. FAU - Zareh, Jonar AU - Zareh J AD - Vascular Research Centre, Heart and Vascular Program, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia. FAU - Jensen, Kirk AU - Jensen K AD - Lifelong Health in Nutrition and Metabolism, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia. FAU - Williamson, Anna AU - Williamson A AD - Vascular Research Centre, Heart and Vascular Program, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia. AD - Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia. FAU - Dimasi, Catherine AU - Dimasi C AD - Vascular Research Centre, Heart and Vascular Program, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia. FAU - Chhay, Pich AU - Chhay P AD - Vascular Research Centre, Heart and Vascular Program, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia. FAU - Toledo-Flores, Deborah AU - Toledo-Flores D AD - Vascular Research Centre, Heart and Vascular Program, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia. FAU - Long, Aaron AU - Long A AD - Vascular Research Centre, Heart and Vascular Program, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia. FAU - Manavis, Jim AU - Manavis J AD - Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia. FAU - Worthington, Michael AU - Worthington M AD - Department of Cardiothoracic Surgery, Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, South Australia, Australia. FAU - Fitridge, Robert AU - Fitridge R AD - Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia. AD - Department of Vascular Surgery, Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, South Australia, Australia. FAU - Di Bartolo, Belinda A AU - Di Bartolo BA AD - The Kolling Institute, The University of Sydney, Sydney, New South Wales, Australia. FAU - Bursill, Christina A AU - Bursill CA AD - Vascular Research Centre, Heart and Vascular Program, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia. AD - Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia. FAU - Nicholls, Stephen J AU - Nicholls SJ AD - Vascular Research Centre, Heart and Vascular Program, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia. AD - Monash Cardiovascular Research Centre, Monash University, Melbourne, Victoria, Australia. FAU - Proud, Christopher G AU - Proud CG AD - Lifelong Health in Nutrition and Metabolism, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia. AD - School of Biological Sciences, University of Adelaide, Adelaide, South Australia, Australia. FAU - Psaltis, Peter J AU - Psaltis PJ AUID- ORCID: 0000-0003-0222-5468 AD - Vascular Research Centre, Heart and Vascular Program, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia. AD - Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia. AD - Department of Cardiology, Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, South Australia, Australia. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - FASEB J JT - FASEB journal : official publication of the Federation of American Societies for Experimental Biology JID - 8804484 RN - 0 (CD36 Antigens) RN - 0 (RNA, Messenger) RN - 97C5T2UQ7J (Cholesterol) RN - EC 2.7.11.20 (Eef2k protein, mouse) RN - EC 2.7.11.20 (Elongation Factor 2 Kinase) SB - IM MH - Animals MH - Atherosclerosis/metabolism MH - CD36 Antigens/*metabolism MH - Cholesterol/metabolism MH - Coronary Artery Disease/metabolism MH - Elongation Factor 2 Kinase/*metabolism MH - Female MH - Foam Cells/*metabolism MH - Humans MH - Leukocytes, Mononuclear/metabolism MH - Macrophages/metabolism MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Monocytes/metabolism MH - Plaque, Atherosclerotic/metabolism MH - RNA, Messenger/metabolism MH - Signal Transduction/physiology OTO - NOTNLM OT - CD36 OT - atherosclerosis OT - eEF2K OT - foam cells OT - macrophages OT - protein translation EDAT- 2022/01/16 06:00 MHDA- 2022/02/15 06:00 CRDT- 2022/01/15 17:05 PHST- 2021/12/14 00:00 [revised] PHST- 2021/06/24 00:00 [received] PHST- 2021/12/27 00:00 [accepted] PHST- 2022/01/15 17:05 [entrez] PHST- 2022/01/16 06:00 [pubmed] PHST- 2022/02/15 06:00 [medline] AID - 10.1096/fj.202101034R [doi] PST - ppublish SO - FASEB J. 2022 Feb;36(2):e22154. doi: 10.1096/fj.202101034R.